30
Participants
Start Date
June 30, 2016
Primary Completion Date
March 31, 2022
Study Completion Date
December 31, 2023
Individual peptide vaccination with adjuvant GM-CSF and Imiquimod
Intradermal injection of a cocktail of 3-5 individual HLA-binding peptides. Subcutaneous injection of adjuvant GM-CSF at vaccination site. Topical administration of Imiquimod at vaccination site.
Charite Universitätsmedizin Berlin, Department of Pediatric Oncology/Hematology, Berlin
University Hospital Düsseldorf, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Düsseldorf
University Medical Center for Children and Adolescents Heidelberg, Heidelberg
University Children's Hospital Tübingen, Tübingen
University Children's Hospital Munich, Center for Pediatric Hematology and Oncology, München
German Cancer Research Center
OTHER
Universität Tübingen
OTHER
University Hospital Tuebingen
OTHER
University Children's Hospital Tuebingen
OTHER